Itaconate, an endogenous mitochondrial metabolite produced by the enzyme aconitate decarboxylase 1 (ACOD1), has emerged as a central regulator of ...
NIMHANS researchers propose a new model for early protein deposits in Parkinson’s, offering insights for future drug ...
DNA interaction could unlock targeted therapeuticsDid you know that every cell in our body has the same DNA inside ...
Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
Prof. Liu Cong from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, ...
Trained immunity provides a unifying framework linking innate immune memory to both protective and maladaptive inflammation ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a ...
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...
Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果